Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ursodeoxycholic acid 150mg/5ml oral liquid
0109010U0AAANAN
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Ursodeoxycholic acid 200mg/5ml oral liquid
0109010U0AAAUAU
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Ursodeoxycholic acid 250mg/5ml oral liquid
0109010U0AAAJAJ
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Ursodeoxycholic acid 25mg/5ml oral liquid
0109010U0AAAQAQ
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Ursodeoxycholic acid 34mg/5ml oral liquid
0109010U0AABGBG
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Ursodeoxycholic acid 37.5mg/5ml oral liquid
0109010U0AABDBD
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Ursodeoxycholic acid 375mg/5ml oral liquid
0109010U0AABCBC
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Ursodeoxycholic acid 500mg capsules
0109010U0AABMBM
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Ursodeoxycholic acid 50mg/5ml oral liquid
0109010U0AAAXAX
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Ursodeoxycholic acid 60mg/5ml oral liquid
0109010U0AABIBI
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Ursodeoxycholic acid 62.5mg/5ml oral liquid
0109010U0AABFBF
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Ursodeoxycholic acid 75mg/5ml oral liquid
0109010U0AAAKAK
|
Ursodeoxycholic acid | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Ursogal 150mg tablets
0109010U0BDAAAA
|
Ursogal | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Ursogal 250mg capsules
0109010U0BDABAB
|
Ursogal | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Ustekinumab 130mg/26ml solution for infusion vials
0105030B0AAAAAA
|
Ustekinumab | Ustekinumab | Gastro-Intestinal System | No data available |
|
Uzpruvo 130mg/26ml concentrate for solution for inf vials
0105030B0BFAAAA
|
Uzpruvo | Ustekinumab | Gastro-Intestinal System | No data available |
|
Valupak Senna 7.5mg tablets
0106020M0BKAAAC
|
Valupak Senna | Senna | Gastro-Intestinal System | No data available |
|
Vantage Pharmacy Constipation Relief 5mg gast res tab
0106020C0BGAAAA
|
Vantage Bisacodyl | Bisacodyl | Gastro-Intestinal System | No data available |
|
Vedolizumab 108mg/.068ml inj pre-filled disposable devices
0105030A0AAACAC
|
Vedolizumab | Vedolizumab | Gastro-Intestinal System | No data available |
|
Vedolizumab 108mg/0.68ml inj pre-filled syringes
0105030A0AAABAB
|
Vedolizumab | Vedolizumab | Gastro-Intestinal System | No data available |
|
Vedolizumab 300mg powder for solution for infusion vials
0105030A0AAAAAA
|
Vedolizumab | Vedolizumab | Gastro-Intestinal System | No data available |
|
Viokase 16 tablets
010904000BBACA0
|
Proprietary compound preparation BNF 0109040 | Other pancreatin preparations | Gastro-Intestinal System | No data available |
|
Viokase 8 tablets
010904000BBABA0
|
Proprietary compound preparation BNF 0109040 | Other pancreatin preparations | Gastro-Intestinal System | No data available |
|
VistaPrep oral powder 110g sachets
0106040M0BKAAAA
|
VistaPrep | Macrogol 3350 | Gastro-Intestinal System | No data available |
|
Vivatak Indigestion Relief 75mg tablets
0103010T0BPAAAP
|
Vivatak | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.